Platinum in PDB 6ffk: Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach
Enzymatic activity of Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach
All present enzymatic activity of Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach:
1.15.1.1;
Protein crystallography data
The structure of Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach, PDB code: 6ffk
was solved by
V.Calderone,
C.Nativi,
F.Cantini,
L.Di Cesare Mannelli,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
28.46 /
1.94
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
156.850,
35.370,
114.590,
90.00,
112.26,
90.00
|
R / Rfree (%)
|
22.6 /
25.6
|
Other elements in 6ffk:
The structure of Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach also contains other interesting chemical elements:
Platinum Binding Sites:
The binding sites of Platinum atom in the Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach
(pdb code 6ffk). This binding sites where shown within
5.0 Angstroms radius around Platinum atom.
In total 4 binding sites of Platinum where determined in the
Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach, PDB code: 6ffk:
Jump to Platinum binding site number:
1;
2;
3;
4;
Platinum binding site 1 out
of 4 in 6ffk
Go back to
Platinum Binding Sites List in 6ffk
Platinum binding site 1 out
of 4 in the Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach
 Mono view
 Stereo pair view
|
A full contact list of Platinum with other atoms in the Pt binding
site number 1 of Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Pt201
b:69.1
occ:0.40
|
PT8
|
A:D7Z201
|
0.0
|
69.1
|
0.4
|
N1
|
A:D7Z201
|
2.0
|
68.3
|
0.4
|
N2
|
A:D7Z201
|
2.0
|
69.2
|
0.4
|
SG
|
A:CYS111
|
2.3
|
54.3
|
1.0
|
CL1
|
A:D7Z201
|
2.4
|
70.4
|
0.4
|
C1
|
A:D7Z201
|
2.8
|
68.7
|
0.4
|
C2
|
A:D7Z201
|
2.8
|
69.0
|
0.4
|
CB
|
A:CYS111
|
3.1
|
50.7
|
1.0
|
PT8
|
B:D7Z201
|
4.2
|
0.3
|
0.3
|
C6
|
A:D7Z201
|
4.2
|
68.6
|
0.4
|
C3
|
A:D7Z201
|
4.2
|
68.9
|
0.4
|
C1
|
B:D7Z201
|
4.4
|
0.1
|
0.3
|
CB
|
A:ILE113
|
4.5
|
48.0
|
1.0
|
N2
|
B:D7Z201
|
4.5
|
0.2
|
0.3
|
N1
|
B:D7Z201
|
4.5
|
0.2
|
0.3
|
CA
|
A:CYS111
|
4.5
|
48.9
|
1.0
|
O
|
A:LEU106
|
4.6
|
60.3
|
1.0
|
CA
|
A:SER107
|
4.7
|
60.6
|
1.0
|
O
|
A:ILE113
|
4.7
|
43.8
|
1.0
|
C
|
A:CYS111
|
4.9
|
49.4
|
1.0
|
CL1
|
B:D7Z201
|
5.0
|
0.2
|
0.3
|
|
Platinum binding site 2 out
of 4 in 6ffk
Go back to
Platinum Binding Sites List in 6ffk
Platinum binding site 2 out
of 4 in the Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach
 Mono view
 Stereo pair view
|
A full contact list of Platinum with other atoms in the Pt binding
site number 2 of Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Pt201
b:0.3
occ:0.30
|
PT8
|
B:D7Z201
|
0.0
|
0.3
|
0.3
|
N1
|
B:D7Z201
|
2.0
|
0.2
|
0.3
|
N2
|
B:D7Z201
|
2.0
|
0.2
|
0.3
|
SG
|
B:CYS111
|
2.4
|
54.1
|
1.0
|
CL1
|
B:D7Z201
|
2.4
|
0.2
|
0.3
|
C1
|
B:D7Z201
|
2.8
|
0.1
|
0.3
|
C2
|
B:D7Z201
|
2.8
|
0.1
|
0.3
|
CB
|
B:CYS111
|
3.4
|
51.5
|
1.0
|
PT8
|
A:D7Z201
|
4.2
|
69.1
|
0.4
|
C6
|
B:D7Z201
|
4.2
|
0.0
|
0.3
|
C3
|
B:D7Z201
|
4.2
|
0.1
|
0.3
|
N1
|
A:D7Z201
|
4.5
|
68.3
|
0.4
|
C1
|
A:D7Z201
|
4.5
|
68.7
|
0.4
|
CB
|
B:ILE113
|
4.6
|
45.6
|
1.0
|
N2
|
A:D7Z201
|
4.6
|
69.2
|
0.4
|
O
|
B:LEU106
|
4.6
|
55.2
|
1.0
|
O
|
B:ILE113
|
4.6
|
44.1
|
1.0
|
CA
|
B:SER107
|
4.7
|
54.7
|
1.0
|
CA
|
B:CYS111
|
4.8
|
51.2
|
1.0
|
CL1
|
A:D7Z201
|
4.9
|
70.4
|
0.4
|
|
Platinum binding site 3 out
of 4 in 6ffk
Go back to
Platinum Binding Sites List in 6ffk
Platinum binding site 3 out
of 4 in the Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach
 Mono view
 Stereo pair view
|
A full contact list of Platinum with other atoms in the Pt binding
site number 3 of Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Pt201
b:65.4
occ:0.30
|
PT8
|
D:D7Z201
|
0.0
|
65.4
|
0.3
|
N1
|
D:D7Z201
|
2.0
|
65.2
|
0.3
|
N2
|
D:D7Z201
|
2.0
|
65.6
|
0.3
|
SG
|
D:CYS111
|
2.3
|
54.4
|
1.0
|
CL1
|
D:D7Z201
|
2.4
|
63.7
|
0.3
|
C1
|
D:D7Z201
|
2.8
|
65.5
|
0.3
|
C2
|
D:D7Z201
|
2.8
|
65.8
|
0.3
|
CB
|
D:CYS111
|
3.2
|
51.3
|
1.0
|
C6
|
D:D7Z201
|
4.2
|
65.8
|
0.3
|
C3
|
D:D7Z201
|
4.2
|
66.2
|
0.3
|
CB
|
D:ILE113
|
4.3
|
49.0
|
1.0
|
N2
|
F:D7Z201
|
4.5
|
70.8
|
0.2
|
PT8
|
F:D7Z201
|
4.5
|
71.3
|
0.2
|
O
|
D:ILE113
|
4.5
|
45.5
|
1.0
|
C1
|
F:D7Z201
|
4.6
|
70.8
|
0.2
|
CA
|
D:CYS111
|
4.6
|
49.3
|
1.0
|
O
|
D:LEU106
|
4.7
|
59.8
|
1.0
|
N1
|
F:D7Z201
|
4.8
|
71.0
|
0.2
|
CA
|
D:SER107
|
4.8
|
58.7
|
1.0
|
CG2
|
D:ILE113
|
4.9
|
50.1
|
1.0
|
CD1
|
D:ILE113
|
5.0
|
58.3
|
1.0
|
C
|
D:CYS111
|
5.0
|
49.4
|
1.0
|
N
|
D:ILE113
|
5.0
|
44.8
|
1.0
|
|
Platinum binding site 4 out
of 4 in 6ffk
Go back to
Platinum Binding Sites List in 6ffk
Platinum binding site 4 out
of 4 in the Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach
 Mono view
 Stereo pair view
|
A full contact list of Platinum with other atoms in the Pt binding
site number 4 of Human Apo-SOD1 Bound to PTCL2(1R,2R-1,4-Dach within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:Pt201
b:71.3
occ:0.20
|
PT8
|
F:D7Z201
|
0.0
|
71.3
|
0.2
|
N2
|
F:D7Z201
|
2.0
|
70.8
|
0.2
|
N1
|
F:D7Z201
|
2.0
|
71.0
|
0.2
|
SG
|
F:CYS111
|
2.3
|
57.1
|
1.0
|
CL1
|
F:D7Z201
|
2.4
|
70.7
|
0.2
|
C2
|
F:D7Z201
|
2.8
|
70.7
|
0.2
|
C1
|
F:D7Z201
|
2.8
|
70.8
|
0.2
|
CB
|
F:CYS111
|
3.2
|
54.2
|
1.0
|
C6
|
F:D7Z201
|
4.2
|
70.7
|
0.2
|
C3
|
F:D7Z201
|
4.3
|
70.8
|
0.2
|
CB
|
F:ILE113
|
4.5
|
51.4
|
1.0
|
PT8
|
D:D7Z201
|
4.5
|
65.4
|
0.3
|
CA
|
F:SER107
|
4.5
|
56.1
|
1.0
|
O
|
F:ILE113
|
4.6
|
50.4
|
1.0
|
O
|
F:LEU106
|
4.6
|
54.2
|
1.0
|
CA
|
F:CYS111
|
4.6
|
53.1
|
1.0
|
N2
|
D:D7Z201
|
4.7
|
65.6
|
0.3
|
C1
|
D:D7Z201
|
4.7
|
65.5
|
0.3
|
O
|
F:GLY108
|
4.9
|
66.8
|
1.0
|
N1
|
D:D7Z201
|
4.9
|
65.2
|
0.3
|
N
|
F:GLY108
|
4.9
|
62.6
|
1.0
|
C
|
F:SER107
|
4.9
|
61.7
|
1.0
|
CG2
|
F:ILE113
|
5.0
|
51.7
|
1.0
|
|
Reference:
F.Cantini,
V.Calderone,
L.Di Cesare Mannelli,
M.Korsak,
L.Gonnelli,
O.Francesconi,
C.Ghelardini,
L.Banci,
C.Nativi.
Interaction of Half Oxa-/Halfcis-Platin Complex with Human Superoxide Dismutase and Induced Reduction of Neurotoxicity. Acs Med Chem Lett V. 9 1094 2018.
ISSN: ISSN 1948-5875
PubMed: 30429951
DOI: 10.1021/ACSMEDCHEMLETT.8B00199
Page generated: Thu Oct 10 11:43:06 2024
|